Nasal antibiotic ointment reduces infection risk after surgery

In what may be the largest clinical trial to evaluate the effectiveness of antimicrobial agents in preventing surgical wound and hospital-based infections caused by Staphylococcus aureus, scientists at the University of Iowa and Johns Hopkins found that an antibiotic ointment, called mupirocin (moo-PIE-roe-sin), smeared inside the nose cut infection rates in half or better.

"Our results carry tremendous implications for reducing S. aureus surgical wound and other hospital-based infections, and for preventing illness and saving lives," says Trish Perl, M.D., associate professor of medicine, director of Hospital Epidemiology and Infection Control at Hopkins and an author of the study published in the June 13 issue of the New England Journal of Medicine.

Staphylococcus aureus is a widely distributed germ that normally resides in the nostrils of an estimated 25 to 30 percent of all hospitalized patients without causing harm. But it can contaminate surgical sites, causing severe and often deadly infections, especially in people with weakened immune systems, and contributing millions of dollars yearly to the costs of health care.

In the study, called MARS (for Mupirocin and the Risk of Staphyloccus aureus Infections), the researchers determined the rate of S. aureus surgical wound infections and other hospital-based infections in 4,030 adult patients who underwent various elective surgical procedures at the University of Iowa Hospitals and Clinics and the Veteran's Affairs Medical Center in Iowa City. Mupirocin antibiotic ointment, or a placebo, was applied to the inside of the nostrils twice daily for up to five days before surgery. Patients were followed for 30 days after surgery to determine if they acquired S. aureus infections.

While mupirocin ointment, made by GlaxoSmithKline, is highly effective at reducing the rate of S. aureus infections in patients undergoing surgery, as with any antibiotic, there is the risk of widespread r

Contact: Trent Stockton
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Nasal contribution to breathing with exercise: The effect of race and gender
2. Could A Nasal Vaccine Finally Get Rid Of The Black Death?
3. Study Shows Athletes Get No Kick From Nasal Strips
4. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
5. Smart antibiotics may result from UCLA research
6. K-State researcher working to improve alternatives to equine antibiotics
7. Bacterial protein recycling factor possible key to new class of antibiotics
8. Bacteria spill their guts to aid researchers in quest for new antibiotics
9. Molecule that blocks key bacterial enzyme may lead to new antibiotics
10. Does antibiotic use contribute to allergies?
11. Tigecycline - Candidate antibiotic produces 74 percent cure rate in cSSSI patients

Post Your Comments:

(Date:9/10/2015)... This report provides detailed descriptions of the ... emerging sensor types that will dominate in the future. ... the wearable technology hype curve in the last five ... feature with all of them is the prominence of ... useful functions. Sensors collect data about the physical and ...
(Date:9/10/2015)... Report Details The global wearable ... previous expectations of revenues, consumer adoption and even technological ... which wearables begin to achieve that mass market acceptance ... reasons is the entrance of Apple to the SmartWatches ... but the overall size of the wearable technology market. ...
(Date:9/10/2015)... Conn. , Sept. 10, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... based ecommerce site, Touch of Modern, will feature ... Wednesday, September 16 th . ... wide range of designer lifestyle products to its 7.2 ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... CORAL SPRINGS, Florida , October 13, 2015 /PRNewswire/ ... (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), ... --> ARRY ), Avanex Life Sciences Corp. (OTCQX: ... Progenix Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... universities and the biotech industry can potentially lead to ...
(Date:10/13/2015)... , Oct. 13, 2015  According to ... services will reach $102 billion by the end ... of the health industry, as it is estimated ... result of laboratory tests. In addition to diagnosing ... to evaluate disease progression, monitor drug treatment and ...
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a commercial ... with the Keck Medicine of the University of Southern California (USC) ... (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association with Pain ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
Breaking Biology Technology:
Cached News: